Skip to content
REQUEST A DEMOCUSTOMER PORTAL
EnsoData
EnsoData
  • About EnsoData
    • Vision
    • Leadership
    • Culture
    • DEI
  • EnsoSleep
    • EnsoSleep for Health Systems
    • Sleep Study Management
    • AI Sleep Scoring
    • ePrescribing
    • Total Sleep Time
    • Pricing
    • Customer Testimonials
  • EnsoSleep PPG
    • Celeste+
    • Remote Physiological Monitoring
  • EnsoTherapy
  • Resources
    • AI Scoring FAQs
    • Case Studies
    • Webinars
    • White Papers & eBooks
    • Research
    • Sleep Tech Corner
    • Blogs
    • EnsoSleep Scoring Certification
    • Events
  • About EnsoData
    • Vision
    • Leadership
    • Culture
    • DEI
  • EnsoSleep
    • EnsoSleep for Health Systems
    • Sleep Study Management
    • AI Sleep Scoring
    • ePrescribing
    • Total Sleep Time
    • Pricing
    • Customer Testimonials
  • EnsoSleep PPG
    • Celeste+
    • Remote Physiological Monitoring
  • EnsoTherapy
  • Resources
    • AI Scoring FAQs
    • Case Studies
    • Webinars
    • White Papers & eBooks
    • Research
    • Sleep Tech Corner
    • Blogs
    • EnsoSleep Scoring Certification
    • Events

EnsoTherapy

EnsoData™ Appoints Chief Commercial Officer, Bobby Cockrill, MBA

EnsoData™ Appoints Chief Commercial Officer, Bobby Cockrill, MBA

EnsoData™, an innovator in AI solutions in sleep medicine, adds Bobby Cockrill, MBA, as Chief Commercial Officer, (CCO) to oversee strategy and execution of sales and marketing functions, grow a world-class team, and continue accelerating adoption across North America.

Read More
Aeroflow Sleep leverages AI-powered Therapy Adherence solution to double patient adherence rates

Aeroflow Sleep leverages AI-powered Therapy Adherence solution to double patient PAP adherence rates

Aeroflow partnered with EnsoData to integrate EnsoTherapy into their sleep coaching workflow. EnsoTherapy is an AI solution that predicts 90-day therapy adherence within days of sleep apnea patients starting treatment. This helps improve PAP adherence rates across their patient population by more than 100%.

Read More
Recent Posts
  • EnsoData™ Appoints Chief Commercial Officer, Bobby Cockrill, MBA
  • EnsoSleep PPG™ adds Body Position, courtesy of ABM’s Night Shift™
  • EnsoData unveils new product offering with AI-driven Remote Physiological Monitoring for Sleep-Disordered Breathing
  • Revolutionizing Sleep Medicine: Bridging the Gap for Undiagnosis of Sleep Apnea Patients with Innovative Technology
  • EnsoData’s Celeste+ mobile application adds three new physical channels to home sleep apnea testing solution: acoustic flow, snore, and actigraphy
Resources
  • Case Studies
  • Webinars
  • White Papers & eBooks
  • Blogs
  • Sleep Tech Corner
Connect With Us
  • 608-509-4704
  • team@ensodata.com
  • 10 E Doty St Suite 449 Madison, WI 53703

Find us on:

Facebook page opens in new windowX page opens in new windowLinkedin page opens in new window
Quick Links
  • Connect
  • Subscribe
  • Privacy Policy
  • Press Coverage and Media Kit
  • Compliance
  • Careers
© 2025 | EnsoData | All Rights Reserved | Privacy Policy
Go to Top